|
1
|
Zeiher AM, Drexler H, Wollschlager H, et
al: Endothelial dysfunction of the coronary microvasculature is
associated with coronary blood flow regulation in patients with
early atherosclerosis. Circulation. 84:1984–1992. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross R: The pathogenesis of
atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109:27–32. 2004.
View Article : Google Scholar
|
|
4
|
Landmesser U, Horni B and Drexler H:
Endothelial function. A critical determinant in atherosclerosis?
Circulation. 19:27–33. 2004.
|
|
5
|
Ross R: Atherosclerosis - an inflammation
disease. N Engl J Med. 340:115–125. 1999. View Article : Google Scholar
|
|
6
|
Altman R: Risk factors in coronary
atherosclerosis athero-inflammation: the meeting point. Thrombosis
J. 1:4–10. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schächinger V and Zeiher AM: Atherogenesis
- recent insights into basic mechanisms and their clinical impact.
Nephrol Dial Transplant. 17:2055–2064. 2002.PubMed/NCBI
|
|
8
|
Ohara Y, Peterson TE, Sayegh HS, et al:
Dietary correction of hypercholesterolemia in the rabbit normalizes
endothelial superoxide anion production. Circulation. 92:898–903.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harrison DG: Cellular and molecular
mechanisms of endothelial cell dysfunction. J Clin Invest.
100:2153–2157. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brandes RP, Barton M, Philippens KM, et
al: Endothelial-derived superoxide anions in pig coronary arteries:
evidence from lucigenin chemiluminescence and historical
techniques. J Physiol. 500:331–342. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Warnholtz A, Nickenig G, Schulz E, et al:
Increased NADH- oxidase-mediated superoxide production in the early
stages of atherosclerosis: evidence for involvement of the
rennin-angiotensin system. Circulation. 99:2027–2033. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rajagopalan S, Kurz S, Münzel T, et al:
Angiotensin II-mediated hypertension in the rat increases vascular
superoxide production via membrane NADH/NADPH oxidase activation. J
Clin Invest. 97:1916–1923. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guzik TJ, West NEJ, Black E, et al:
Vascular superoxide production by NAD(P)H oxidase association with
endothelial dysfunction and clinical risk factors. Circ Res.
86:85–90. 2000. View Article : Google Scholar
|
|
14
|
Rueckschloss U, Galle J, Holtz J, et al:
Induction of NAD(P) oxidase by oxidized low-density lipoprotein in
human endothelial cells: antioxidative potential of
hydroxymethylglutaryl coenzyme A reductase inhibitor therapy.
Circulation. 104:1767–1772. 2001. View Article : Google Scholar
|
|
15
|
Sumimoto H, Hata K, Mizuki K, et al:
Assembly and activation of the phagocyte NADPH oxidase. Specific
interaction of the N-terminal Src homology 3 domain of p47PHOX with
p22PHOX is required for activation of the NADPH oxidase. J Biol
Chem. 271:22152–22158. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ushio-Fukai M, Zafari AM, Fukai T, et al:
p22PHOX is a critical component of the superoxide generating
NADH/NADPH oxidase system and regulates angiotensin II-induced
hypertrophy in vascular smooth muscle cells. J Biol Chem.
271:23317–23321. 1996. View Article : Google Scholar
|
|
17
|
Sundaresan M, Yu ZX, Ferrans VJ, Irani K
and Finkel T: Requirement for generation of
H2O2 for platelet derived growth factor
signal transduction. Science. 270:296–299. 1995.
|
|
18
|
Zalba G, Jose GS, Moreno MU, et al: NADPH
oxidase mediated oxidative stress: genetic studies of p22PHOXgene
in hypertension. Antioxid Redox Signal. 7:1327–1336. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wyche KE, Wang SS, Griendling KK, et al:
C242T CYBA polymorphism of NADPH oxidase is associated with reduced
respiratory burst in human neutrophils. Hypertension. 43:1246–1251.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guzik TJ, West NE, Black DE, et al:
Functional effects of the C242T polymorphism in the NAD(P)H oxidase
p22PHOX gene on vascular superoxide production in atherosclerosis.
Circulation. 102:1744–1747. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laursen JB, Rajagopalan S, Galis Z, et al:
Role of superoxide in angiotensin II induced but not catecholamine
induced hypertension. Circulation. 95:588–593. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mollnau H, Wendt M, Szocs K, et al:
Effects of angiotensin II infusion on the expression and function
of NAD(P)H oxidase and components of nitric oxide/cGMPsignaling.
Circ Res. 90:58–65. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fukui T, Ishizaka N, Rajagopalan S, et al:
p22PHOX mRNA expression and NADPH oxidase activity are increased in
aortas from hypertensive rats. Circ Res. 80:45–51. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paravincini TM and Touyz RM: Redox
signaling in hypertension. Cardiovasc Res. 71:247–258. 2006.
View Article : Google Scholar
|
|
25
|
Suzuki H, Swei A, Zweifach BW, et al: In
vivo evidence for microvascular oxidative stress in spontaneously
hypertensive rats: hydroethidinemicrofluorography. Hypertension.
25:1083–1089. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakazono K, Watanabe N, Matsuno K, et al:
Does superoxide underlie the pathogenesis of hypertension? Proc
Natl Acad Sci USA. 88:10045–10085. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Higashi Y, Sasaki S, Nakagawa K, et al:
Endothelial function and oxidative stress by products in human
hypertension. Hypertension. 41:1096–1101. 2003. View Article : Google Scholar
|
|
28
|
Redon J, Oliva MR, Tormos C, et al:
Antioxidant activities and oxidative stress byproducts in human
hypertension. Hypertension. 41:1091–1101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li L, Fink GD, Watts SW, et al: Endothelin
I increases vascular superoxide via endothelin (A)-NAD(P)H oxidase
pathway in low rennin hypertension. Circulation. 107:1053–1058.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beswick RA, Dorrance AM, Leite R, et al:
NADH/NADPH oxidase and enhanced superoxide production in the
mineralo- corticoid hypertensive rat. Hypertension. 38:1107–1111.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pettit AI, Wong RK, Lee V, et al:
Increased free radical production in hypertension due to increased
expression of NADPH oxidase subunit p22PHOX in lymphoblast cell
lines. J Hypertens. 20:677–683. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fortuno A, Olivan S, Beloqui O, et al:
Association of increased phagocytic NAD(P)H oxidase dependent
superoxide production with diminished nitric oxide generation in
essential hypertension. J Hypertens. 22:2169–2175. 2004. View Article : Google Scholar
|
|
33
|
Zalba G, Beaumont FJ, San Jose G, et al:
Vascular NADH/NADPH oxidase is involved in enhanced superoxide
production in spontaneously hypertensive rats. Hypertension.
35:1055–1061. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Castejon AM, Bracero J, Hoffman IS, et al:
NAD(P)H oxidase p22PHOXgene C242T polymorphism, nitric oxide
production, salt sensitivity and cardiovascular risk factors in
Hispanics. J Hum Hypertens. 20:772–779. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nasti S, Balbi M, Fabbi P, et al: CYBA
polymorphism associated with oxidative stress in Italian patients
with early onset of coronary artery disease. Ital Heart J.
3:S52–S54. 2002.
|
|
36
|
Moreno MU, Jose GS, Fortuno A, et al: The
C242T CYBA polymorphism of NADPH oxidase is associated with
essential hypertension. J Hypertens. 24:1299–1306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Inoue N, Kawashima S, Kanazawa K, et al:
Polymorphism of the NADH/NADPH oxidase p22PHOX gene in patients
with coronary artery disease. Circulation. 97:135–137. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fan M, Kähönen M, Rontu R, et al: The
p22PHOX C242T gene polymorphism is associated with a reduced risk
of angiographically verified coronary artery disease in a high-risk
Finnish Caucasian population. The Finnish cardiovascular study. Am
Heart J. 152:538–542. 2006. View Article : Google Scholar
|
|
39
|
Shimo-Nakanishi Y, Hasebe T, Suzuki A, et
al: Functional effects of NAD(P)H oxidase p22PHOX C242T mutation in
human leukocytes and association with thrombotic cerebral
infraction. Atherosclerosis. 175:109–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ito D, Murata M, Watanabe K, et al: C242T
polymorphism of NADPH oxidase p22PHOX gene and ischemic
cerebrovascular disease in the Japanese population. Stroke.
31:936–939. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cai H, Duarte N, Wilcken DE, et al:
NADH/NADPH oxidase p22PHOX C242T polymorphism and coronary artery
disease in the Australian population. Eur J Clin Invest.
29:744–748. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cahilly C, Ballantyne CM, Lim DS, et al: A
variant of p22PHOX, involved in generation of reactive oxygen
species in the vessel wall, is associated with progression of
coronary atherosclerosis. Circ Res. 86:391–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hyashi Okano R, Yamasaki Y, Kajimoto Y, et
al: Association of NAD(P)H oxidase p22PHOX gene variation with
advanced carotid atherosclerosis in Japanese type 2 diabetes.
Diabetes Care. 26:458–463. 2003.PubMed/NCBI
|
|
44
|
Nasti S, Spallarossa P, Aitieri P, et al:
C242T polymorphism in CYBA gene (p22phox) and risk of coronary
artery disease in a population of Caucasian Italians. Dis Markers.
22:167–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schachinger V, Britten MB, Dimmeler S, et
al: NADH/NADPH oxidase p22PHOX gene polymorphism is associated with
improved coronary endothelial vasodilator function. Eur Heart J.
22:96–101. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schneider MP, Hilgers KF, Huang Y, et al:
The C242T p22PHOX polymorphism and endothelium-dependent
vasodilation in patients with hypercholesterolemia. Clin Sci.
105:97–103. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li A, Prasad A, Mincemoyer R, et al:
Relationship of the C242T p22PHOX gene polymorphism to angiographic
coronary artery disease and endothelial function. Am J Med Genet.
86:57–61. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Levey AS, Bosch JP, Lewis JB, et al: A
more accurate method to estimate glomerular filtration rate from
serum creatinine: a new prediction equation. Modification of Diet
in Renal Disease Study Group. Ann Intern Med. 130:461–470. 1999.
View Article : Google Scholar
|
|
49
|
Inoguchi T, Li P, Umeda F, et al: High
glucose level and free fatty acid stimulate reactive oxygen species
production through protein kinase C-dependent activation of NADPH
oxidase in cultured vascular cells. Diabetes. 49:1939–1945. 2000.
View Article : Google Scholar
|
|
50
|
Hink U, Li H, Mollnau H, et al: Mechanisms
underlying endothelial dysfunction in diabetes mellitus. Circ Res.
88:E14–E22. 2001. View Article : Google Scholar : PubMed/NCBI
|
